Sonnet Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $9,076 | $0 | $0 | $18 |
Gross Profit | 4,538 | -21 | -20 | -1 |
EBITDA | -3,170 | -3,507 | -3,848 | -1,258 |
EBIT | -3,173 | -3,528 | -3,868 | -1,278 |
Net Income | -3,128 | -3,505 | 365 | -1,168 |
Net Change In Cash | 9,076 | 0 | 0 | 18 |
Free Cash Flow | -3,170 | -3,081 | 723 | -3,091 |
Cash | 149 | 3,554 | 3,786 | 3,021 |
Basic Shares | 940 | 5,037 | 4,617 | 3,797 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $18 | $147 | $349 | $483 |
Gross Profit | 18 | -11,666 | 256 | -16,150 |
EBITDA | -11,849 | -18,716 | -29,576 | -24,992 |
EBIT | -18,792 | -29,669 | -25,087 | |
Net Income | -7,437 | -18,832 | -29,774 | -25,005 |
Net Change In Cash | 18 | 147 | 349 | 483 |
Free Cash Flow | -8,607 | -21,785 | -28,583 | -22,555 |
Cash | 149 | 2,274 | 3,052 | 27,622 |
Basic Shares | 655 | 1,038 | 197 | 79 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$10.39 |
2024-06-30 | -$0.70 |
2024-03-31 | $0.07 |
2023-12-31 | -$0.31 |
